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From the Department of Chemical Pathology, York District Hospital, Wigginton Road, York, Y03 7HE, UK Additional key phrases: phenylalanine: monitoring in pregnancy: fetal abnormalities; dietary control Phenylalanine is an essential amino acid. Deficiency of the enzyme phenylalanine hydroxylase in the liver prevents conversion of phenylalanine to tyrosine. Excess phenylalanine is converted to phenyl pyruvate and phenyllactate which appear in the urine. It is the accumulation of phenylalanine and its metabolites which is thought to inhibit mental development and cause brain damage in phenylketonuria (PKU). Tyrosine is necessary for synthesis of thyroxine, melanin, dihydroxyphenylalanine and catecholamines.
PK U was first identified in 1934 and is inherited as an autosomal recessive gene. The incidence in the UK is I in 10000 live births with a carrier frequency of I in 50. 1 Affected babies are detected by the national neonatal screening programme for PKU. Treatment should begin as soon as possible, by reducing phenylalanine in the diet and adding 'protein substitute'. Until recently, strict dietary restriction was continued until the age of about ten years, when it was relaxed, and was frequently dropped altogether at 17 years. There is now an increasing tendency to maintain strict dietary restriction until adulthood? with a lesser degree of restriction in adult life.
Maternal PKU is associated with serious obstetric complications and fetal abnormalities.l-' Here we report a woman with PKU who has had five pregnancies over 8 years.
CASE HISTORY
A 21-year-old woman who had been diagnosed as phenylketonuric at 6 weeks of age presented to her general practitioner in 1985. She desired a Correspondence: Dr H Wilkinson. pregnancy and reported 7 weeks amenorrhoea. Twelve months previously, a pregnancy had been terminated at 18 weeks; the fetus was malformed with only one centrally placed eye. She was admitted to hospital for dietary advice as she was on unrestricted protein intake. An ultrasound scan showed a fetus of 13 weeks gestation. She was offered a termination, but this was refused. Her pregnancy continued on a phenylalanine-restricted protein substitute diet.
Serum phenylalanine concentration at presentation had been 960J.Lmol/L (48-110) and tyrosine 35 J.Lmol/L (22-87). Weekly fasting blood samples were monitored for phenylalanine and tyrosine concentrations. The aim was to keep serum phenylalanine below 600 J.Lmol/L and tyrosine over 300 J.Lmol/L and this was achieved. She delivered a healthy, normal boy weighing 2.36 kg at 34 weeks gestation. The baby did not have PKU, as shown by a negative screen test on the sixth day.
She has subsequently had three further pregnancies by a different father. In each case, a phenylalanine-restricted diet was started early in the pregnancy (at between 9 and 15 weeks). The second child (third pregnancy), a girl weighing 1.49 kg, was born by emergency caesarean section at 30 weeks gestation. She had respiratory distress and coarctation of the aorta which was repaired surgically. Her serum phenylalanine on day 6 was 141J.Lmol/L. The next baby was born at 34 weeks gestation. Labour was induced due to poor fetal growth. Birth weight was 1.9 kg. The baby suffered respiratory distress but had no congenital abnormalities and serum phenylalanine on day 6 was normal at 138J.Lmol/L.
The fifth pregnancy resulted in premature delivery at 30 weeks. The baby weighed 1.00 kg and had respiratory distress syndrome, apnoea and bradycardia, but serum phenylalanine was normal at 75 J.Lmol/L. Data concerning all five pregnancies are summarized in Table I . All four children have been psychometrically tested and none has a low There is good evidence to show that reducing phenylalanine concentrations prior to conception and during pregnancy can reduce poor fetal outcome.l-v" Without dietary regulation. there is a one-in-two incidence of fetal distress or abnormality. There is also evidence to show that phenylalanine excess leads to an increase in myelin turnover. Magnetic resonance imaging studies have shown abnormal myelin structure in a proportion of older children and adolescents whose phenylalanine concentrations are greater than 400-500/lmol/L. 4 Overt neurological deterioration may occur and there is therefore a move to advise PK U sufferers to limit their phenylalanine intake lifelong."
The laboratory has a vital role to play in the PK U monitoring programme for pregnant women. Blood phenylalanine concentrations should be measured weekly with the aim of keeping them between 60-250,lmol/L.2 This monitoring can be achieved simply by supplying the patient with packs containing all the material necessary for the collection of finger prick blood samples at home. These can then be sent by post in pre-paid padded envelopes to the laboratory for phenylalanine measurement. There should be good liaison between the home laboratory. the specialist laboratory which performs the assay. the dietician and the patient, to enable adjustment of phenylalanine intake according to serum concentration. Those patients who have not observed a strict (or any) diet, during adulthood may need a short period of inpatient supervision before attempting to become pregnant. ' It is recommended that where the initial phenylalanine concentration is greater than 900/lmol/L, as in our patient at presentation. termination should be offered, as the likelihood of fetal malformation is high.? Even a concentration greater than 700 Jlmol/L poses a risk to fetal brain growth. Furthermore, there is a positive amino acid gradient of 1:1·5 across the placenta, so the fetus is exposed to an even higher phenylalanine concentration than the mother. When this patient had her first child, the recommended phenylalanine concentration was less than 600 Jlmol/L. I Now, the upper limit thought to be acceptable is 250 Jlmol/L. Dietary recommendations are 400 mg phenylalanine and 2267 kcal/day. Many natural foods (meat, fish, eggs, bread, dairy products) can be replaced by protein substitutes containing all other nutrients but low amounts of phenylalanine.'
The problems of PKU are not over in adult life, since all adults ideally require continuing dietary control. Women who wish to become pregnant require an even stricter regimen than they experienced in childhood. It is important that these women re-establish good control before conception, in order to minimize the risk of fetal abnormalities. It is clear that if vigilance is not observed in today's PK U mothers, the mental and physical abnormalities will simply skip a generation and all the good achieved over the past 30 years through neonatal screening will be lost.
